Kyle Piskel, Chief Financial Officer at Adaptive Biotechnologies Corp (ADPT), sold 3,115 shares at $13.04 ($41K) on 2026-05-18, disclosed to the SEC on 2026-05-20.
Open-market sale of $41k ADPT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ADPT | SELL | 2026-01-14 | $77K | — | Filing → |
| ADPT | SELL | 2025-12-02 | $3.2M | — | Filing → |
| ADPT | SELL | 2025-11-18 | $3K | — | Filing → |